Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 - Wikidata - wikimedia - TriplyDB

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

http://www.wikidata.org/entity/Q24568313

about

sameAs

Mpl traffics to the cell surface through conventional and unconventional routes Role of tyrosine-kinase inhibitors in myeloproliferative neoplasms: comparative lessons learned Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β Recent advances in understanding myelofibrosis and essential thrombocythemia Overcoming treatment challenges in myelofibrosis and polycythemia vera: the role of ruxolitinib Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms Genomic diversity in myeloproliferative neoplasms: focus on myelofibrosis The Role of PTEN in Myeloid Malignancies Genomic landscape of megakaryopoiesis and platelet function defects Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis Inflammation as a Keystone of Bone Marrow Stroma Alterations in Primary Myelofibrosis MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors Guidelines for the management of myeloproliferative neoplasms Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation Chronic neutrophilic leukemia: a clinical perspective JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F Clinical potential of pacritinib in the treatment of myelofibrosis Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms Review article: portal vein obstruction--epidemiology, pathogenesis, natural history, prognosis and treatment Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and management Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis Pathophysiological Significance of Store-Operated Calcium Entry in Megakaryocyte Function: Opening New Paths for Understanding the Role of Calcium in Thrombopoiesis Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors Novel therapies for myelofibrosis The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control Refractory anemia with ring sideroblasts and RARS with thrombocytosis Calreticulin (CALR) mutation in myeloproliferative neoplasms (MPNs)N-Glycan-based ER Molecular Chaperone and Protein Quality Control System: The Calnexin Binding Cycle A novel mutation in EED associated with overgrowth Age-related mutations associated with clonal hematopoietic expansion and malignancies Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms The European Hematology Association Roadmap for European Hematology Research: a consensus document

P2860

Q24299221-A78EE7DD-6E64-4CFB-8549-1B4FC465DD3C Q26738514-00B3E8E6-74FF-4C56-AFBB-34DB90036C1E Q26744113-D64E1492-1A28-436E-828A-50287924FE7C Q26745943-B537F994-639B-4E61-BA4B-EE58E1B71CBE Q26748543-22DC2E30-C04E-438F-8A9F-0173F4DB3B3E Q26750696-B02636F0-74EB-4582-A5BB-9E7685EA0791 Q26752940-62EF99A5-0939-4DD6-AB66-DF55FB817AED Q26766319-E7AE7546-E1E4-4F6E-AD88-8D2FCB6E3D1D Q26770330-201B4A9B-0294-490C-B726-99F8CAFB1B3F Q26770608-E80CB309-567E-4086-A544-5882AB979D7D Q26770869-D3118A95-28E9-4F24-AED5-C11F3FA396F8 Q26772881-E7B780B9-9A77-4714-8AA2-F36515C096D0 Q26774212-FFB1BF95-7A89-42A8-9B70-BC5844B4B3B1 Q26775996-A49A49C8-1ED5-4F46-881B-C3F7C602E774 Q26777265-614E9E3E-7533-4AB8-BB51-FD44670E301D Q26778326-654754ED-B8AB-40FA-B39D-A0E920D27030 Q26778929-C22A54A6-34D3-4E2A-9314-9DA321D8D1BC Q26779929-2228EEBE-3E9C-41EE-85E8-31A909F67740 Q26779960-60AE5EA2-3B17-4796-B4D2-D78A04A673AF Q26781167-4C0369D7-86F3-4C63-803A-10BE116DACF8 Q26782539-9F733809-B9AD-4599-BC2E-00FB04A877DA Q26795666-7A2EFF46-ACE5-4719-AF91-FE250B3ADBAA Q26796450-B451A2D1-4D96-48ED-8B91-26CF8445AE20 Q26799790-3C5B9582-0848-43D1-A5AC-77F2C1E644A3 Q26825552-CAC22CDA-9AF8-4D29-BD43-35C8CE5B5113 Q26851894-0A2331E1-6C41-444F-8A9C-01EE6C8CF7AF Q26996258-B3AACDE4-0113-4D76-ABC5-F8E1A96E0957 Q27009366-CCF91163-295F-4395-825D-CA670AE06A42 Q27853043-553BA125-C1DB-4972-A594-69A240E36E36 Q28069839-44A731D2-609D-4E13-9152-3BD3E6497570 Q28073296-64E4052F-82B7-4E41-8FAE-3CF97154F3EC Q28081693-429F6A76-A74F-4181-AF2F-A734F751F3E6 Q28082685-BB3ACB13-8291-4A15-9DA3-7901F93EC12B Q28083238-EDF2578B-087B-49DA-9FBD-C175A73C97A9 Q28084727-52B7C980-A961-453A-8D99-4D31BEB8DDAE Q28085581-0094B427-DE9B-44C7-9700-CC80599C143A Q28259120-5CA1F618-0402-4A30-93EC-032D23296204 Q28387160-A2DB9864-0B14-45B9-B1C3-F09ED688B49C Q28392728-1035BF8D-5B1E-40E9-982F-4D312D75ADEC Q28830861-6FDF1F79-6237-49B2-A80E-A96E119877A6

P2860

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

http://www.wikidata.org/entity/Q24568313

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

@ast

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

@en

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

@nl

type

label

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

@ast

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

@en

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

@nl

prefLabel

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

@ast

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

@en

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

@nl

P1433

Q24568313-597AEA66-3F78-44A7-A531-94D8492F81EA

P1476

Q24568313-D8F8D5FD-6E15-4824-B2C7-FB6F6D170BCF

P2093

Q24568313-0299CB3E-A100-4972-B795-80FFB55B2A0E

Q24568313-0323E58C-2D13-4BBD-B5E4-3BF914648A12

Q24568313-06B96D28-EB2E-463C-A203-F9CF27BDC705

Q24568313-154DE233-1DDE-4C2C-A6BA-8A403C54EC30

Q24568313-179B7C62-91DC-44C0-A029-65940274838E

Q24568313-25B0E66B-6FE5-42C0-9D57-8F313978F1EC

Q24568313-32FBD4D2-9798-490F-838C-0CB24D1DBABD

Q24568313-382A105C-E8D5-4FEE-BD7E-83A77636672D

Q24568313-3CB1FE8F-B1DD-48C2-B123-0200206D6203

Q24568313-3EA2E307-9BF7-46D9-871E-3D6EECCA5876

P2860

Q24568313-04ECB70F-AD37-4AAA-B409-4D4563DEF00F

Q24568313-0F8C611D-C28B-4B80-A391-AD063B25A65E

Q24568313-18506936-C794-4804-B490-1BC07BF48465

Q24568313-1C4A2E60-ADAC-48C1-8FCB-0DFDD2602F80

Q24568313-22CD48C5-F517-44AE-819F-B60B73388FBE

Q24568313-2868B76C-B2C4-4069-8738-A31C92DDB570

Q24568313-290748CC-A41C-4616-BCDD-E5EAF8C9846E

Q24568313-2F72B776-8683-4820-B7F5-B28851E4A400

Q24568313-468C8A15-E1E4-43A0-B96F-BF6094E9DD5D

Q24568313-46A18485-C43D-4AB0-8483-07512DF8BAE3

P304

Q24568313-CC7FC596-6767-4141-BC8A-7ED3A0DB97B5

P31

Q24568313-D2626B77-EFE3-42C4-B469-3F2848382E92

P3181

Q24568313-A373C617-943F-4CC0-8678-E78D3D7859B7

P356

Q24568313-926F0B74-F71F-4498-BE0A-4FB47E3C4EC6

P407

Q24568313-51B357C9-9D10-43D9-BDDE-D6913CE61261

P433

Q24568313-D4F2B704-A2A5-4EF0-9F42-971489CA1781

P478

Q24568313-F729E41F-0B13-478B-86AF-2A63428D367A

P50

Q24568313-0E9FC0BB-1006-43E2-A40F-B5E2EFD65B46

Q24568313-108CDBD2-AEE7-450E-B746-0516EDF40103

Q24568313-2747D529-6E3A-4B0F-9DE0-D5C4C53C6A80

Q24568313-41465F78-63BF-4322-8F9A-5113515E03F3

Q24568313-5C532DBF-D832-49C9-B427-78AE7605B714

Q24568313-7479677B-F3DB-4AD5-988A-2015C710471E

Q24568313-8CE126AD-0DAC-4985-8C99-0D868882766E

Q24568313-A1D5A142-1436-4813-940B-3615A8AAE485

Q24568313-A97A1F49-EC2E-4EE7-870A-6093532022C5

Q24568313-BD199765-7FD6-4C3A-BC26-5C674F981F85

P577

Q24568313-2EA0A0A8-AD98-4C93-A912-640AFAB41351

P698

Q24568313-E57C7248-8891-48F3-8BE7-7F15003665A5

P932

Q24568313-8167ED1C-34D5-4844-846A-F8D6A8F7830F

P3181

P356

P1433

The New England Journal of Medicine

P1476

Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2

@en

P2093

A Aziz

http://www.w3.org/2001/XMLSchema#string

A L Godfrey

http://www.w3.org/2001/XMLSchema#string

A M Vannucchi

http://www.w3.org/2001/XMLSchema#string

A P Butler

http://www.w3.org/2001/XMLSchema#string

A V Jones

http://www.w3.org/2001/XMLSchema#string

B Robinson

http://www.w3.org/2001/XMLSchema#string

C A Ortmann

http://www.w3.org/2001/XMLSchema#string

C Keohane

http://www.w3.org/2001/XMLSchema#string

C Maclean

http://www.w3.org/2001/XMLSchema#string

C N Harrison

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

Structural and Functional Relationships between the Lectin and Arm Domains of Calreticulin

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

Guideline for investigation and management of adults and children presenting with a thrombocytosis

Patterns of somatic mutation in human cancer genomes

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

P304

2391-2405

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

290062

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1312542

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

369

http://www.w3.org/2001/XMLSchema#string

P50

Charlie E Massie

Paola Guglielmelli

Heather P Harding

P577

2013-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24325359

http://www.w3.org/2001/XMLSchema#string

P932

3966280

http://www.w3.org/2001/XMLSchema#string